🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2006-08
Trial ID
NCT00372593
This phase I trial studies the best dose and side effects of liposomal cyta...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-05-21
Trial ID
NCT04915612
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of anti-OX40 ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2017-12-27
Trial ID
NCT03390296
Acute myeloid leukemia (AML) is among the most common hematologic malignanc...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2017-07-07
Trial ID
NCT03226418
This phase II trial studies the side effects and how well liposome-encapsul...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2018-11-07
Trial ID
NCT03672539
Treatments Being Tested
This phase Ib trial studies the best dose of gemtuzumab ozogamicin when giv...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2019-07-18
Trial ID
NCT03904251
Treatments Being Tested
This phase II trial studies the side effects and how well fludarabine phosp...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2007-04-04
Trial ID
NCT00801489
Vyxeos Vyxeos is a liposomal-encapsulated combination of cytarabine and dau...
Status
Active Not Recruiting
Location
Shaare Zedek Medical Center
Start Date
2022-08-07
Trial ID
NCT05599360
RATIONALE: Giving combination chemotherapy before a stem cell transplant he...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2002-12-19
Trial ID
NCT00049517
This phase III trial compares standard chemotherapy to therapy with liposom...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-07-21
Trial ID
NCT04293562
Treatments Being Tested